Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease.

Front Immunol · 2022 · PMC9294156 · PMID 35865529

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In addition, mRNA-vaccinated patients who were treated with thiopurines showed a trend towards lower antibody concentrations compared to patients who were not treated with thiopurines (geometric mean [95% confidence interval]: 4523 [3574-5724] vs . 5634 [4561-6958] AU/ml, P=0.182).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.